Recently, research spearheaded by Gan Boyi et al. substantiates that elevated SLC7A11 expression predisposes cells to disulfidptosis, hinting at a potential functional role for disulfidptosis in glioma pathobiology. Here, SLC7A11 is linked to central nervous system cancer.